Molecularly Imprinted Polymer-Silica Hybrid Particles for Biomimetic Recognition of Target Drugs

<div>(a) A comparison of the relative absorbance shifts of standard amlodipine solution treated with MIP-silica and NIP-silica hybrid particles, respectively, while (b) shows the relative absorbance shifts for amlodipine and aspirin drugs after treatment with MIP-silica hybrid particles: The greater absorbance shift for amlodipine represents selectivity of the particles.</div>

Advances in Polymer Technology

fig4

Figure 4

Figure 4: Molecularly Imprinted Polymer-Silica Hybrid Particles for Biomimetic Recognition of Target Drugs 